SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-004258
Filing Date
2022-03-22
Accepted
2022-03-22 08:28:45
Documents
14
Period of Report
2022-03-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cinc-20220322.htm   iXBRL 8-K 51634
2 EX-99.1 cinc-ex99_1.htm EX-99.1 125792
3 GRAPHIC img73281002_0.jpg GRAPHIC 2253
  Complete submission text file 0000950170-22-004258.txt   317528

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cinc-20220322.xsd EX-101.SCH 2477
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cinc-20220322_pre.xml EX-101.PRE 10769
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cinc-20220322_lab.xml EX-101.LAB 14668
8 EXTRACTED XBRL INSTANCE DOCUMENT cinc-20220322_htm.xml XML 5112
Mailing Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116 8445311834
CinCor Pharma, Inc. (Filer) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41201 | Film No.: 22757243
SIC: 2834 Pharmaceutical Preparations